Lynparza 150 mg film-coated tablets, Lynparza 100 mg film-coated tablets
Phase 2 small_molecule active
Quick answer
Lynparza 150 mg film-coated tablets, Lynparza 100 mg film-coated tablets for recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active